Literature DB >> 30270113

Antimicrobial resistance in cystic fibrosis: Does it matter?

Patrick A Flume1, Valerie J Waters2, Scott C Bell3, Donald R Van Devanter4, J Stuart Elborn5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30270113     DOI： 10.1016/j.jcf.2018.08.015

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  3 in total

1.  The use of antimicrobial susceptibility testing in pediatric cystic fibrosis pulmonary exacerbations.

Authors:  Jonathan D Cogen; Kathryn B Whitlock; Ronald L Gibson; Lucas R Hoffman; Donald R VanDevanter
Journal:  J Cyst Fibros       Date:  2019-05-28       Impact factor: 5.482

2.  Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation.

Authors:  Claire L Keating; Jonathan B Zuckerman; Pradeep K Singh; Matthew McKevitt; Oksana Gurtovaya; Mark Bresnik; Bruce C Marshall; Lisa Saiman
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

3.  Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs.

Authors:  Gisli G Einarsson; Bart M Vanaudenaerde; Christopher D Spence; Andrew J Lee; Mieke Boon; Geert M Verleden; J Stuart Elborn; Lieven J Dupont; Dirk Van Raemdonck; Deirdre F Gilpin; Robin Vos; Stijn E Verleden; Michael M Tunney
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.